ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins#835370
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy#136268
- Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes#363548
- Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis#154821
- Feasibility Study of a Transdermal Continuous Glucose Monitoring (CGM) System in Diabetic Patients#442037
Record · ID 226226
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive